172 related articles for article (PubMed ID: 17939339)
1. Mediastinal single nodal relapse of a nasal NK/T cell lymphoma.
Rhee KH; Hong SC; An JM; Huh J; Sook RJ; Lee JS; Suh C
Korean J Intern Med; 2007 Sep; 22(3):201-5. PubMed ID: 17939339
[TBL] [Abstract][Full Text] [Related]
2. [Nasal NK/T-cell lymphoma: about two rare cases].
Bouayad N; Oubelkacem N; Bono W; Masbah O; Bouhafa T; Elmazghi A; Khalid H
Pan Afr Med J; 2018; 30():141. PubMed ID: 30374387
[TBL] [Abstract][Full Text] [Related]
3. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy.
Sanda T; Lida S; Ito M; Tsuboi K; Miura K; Harada S; Komatsu H; Wakita A; Inagaki H; Ueda R
Int J Hematol; 2002 Feb; 75(2):195-200. PubMed ID: 11939269
[TBL] [Abstract][Full Text] [Related]
5. Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis.
Hallak B; Cairoli A; Bouayed S; Berthod G
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31413056
[TBL] [Abstract][Full Text] [Related]
6. Optimal specimen site for diagnosis of nasal T/NK cell lymphoma and treatment including bone marrow transplantation.
Sakamoto M; Miyairi Y; Ishizawa M
ORL J Otorhinolaryngol Relat Spec; 2003; 65(5):275-8. PubMed ID: 14730183
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
8. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of localized nasal NK/T-cell lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2008 Aug; 49(8):553-8. PubMed ID: 18800601
[No Abstract] [Full Text] [Related]
10. Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
Xu J; Xu X; Chen J; Wang J; Jiang C; Lv C; Chen B
Medicine (Baltimore); 2021 Mar; 100(10):e24824. PubMed ID: 33725836
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Kouzaki H; Kitanishi T; Kitano H; Suzuki M
Auris Nasus Larynx; 2004 Mar; 31(1):79-83. PubMed ID: 15041059
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.
Ma HH; Qian LT; Pan HF; Yang L; Zhang HY; Wang ZH; Ma J; Zhao YF; Gao J; Wu AD
Med Oncol; 2010 Sep; 27(3):798-806. PubMed ID: 19685292
[TBL] [Abstract][Full Text] [Related]
13. [Extra-nodal NK/T-cell lymphoma, nasal type presenting as orbital cellulitis].
Amri GE; Zalagh M; Benariba F
Pan Afr Med J; 2018; 31():8. PubMed ID: 30918537
[TBL] [Abstract][Full Text] [Related]
14. Sinonasal NK/T-cell lymphoma.
Hmidi M; Kettani M; Elboukhari A; Touiheme N; Messary A
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):145-7. PubMed ID: 23273887
[TBL] [Abstract][Full Text] [Related]
15. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
Wang ZY; Li YX; Wang WH; Jin J; Wang H; Song YW; Liu QF; Wang SL; Liu YP; Qi SN; Fang H; Liu XF; Yu ZH
Blood; 2009 Nov; 114(23):4771-6. PubMed ID: 19812381
[TBL] [Abstract][Full Text] [Related]
16. T/NK cell lymphoma presenting as a "blocked nose".
Ketharanathan N; van Kipshagen PJ; Vasmel W; Barbé E; de Vries N
Eur Arch Otorhinolaryngol; 2008 Sep; 265(9):1131-4. PubMed ID: 18188576
[TBL] [Abstract][Full Text] [Related]
17. A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.
Cao J; Lan S; Shen L; Si H; Zhang N; Li H; Guo R
Oncotarget; 2017 Mar; 8(12):20362-20370. PubMed ID: 27901491
[TBL] [Abstract][Full Text] [Related]
18. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.
Huang H; Lin Z; Lin X; Cai Q; Xia Z; Jiang W
Leuk Lymphoma; 2011 Jun; 52(6):1041-8. PubMed ID: 21599590
[TBL] [Abstract][Full Text] [Related]
20. [Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review].
Tissir R; Rais H; Tazi I
Pan Afr Med J; 2020; 37():22. PubMed ID: 33062124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]